[1] |
张文君,陈燕,潘勐.原发性肝癌合并癌栓的研究进展.中国普通外科杂志,2015,24:1017-1021.
|
[2] |
张立洁, 彭泉, 芦东徽,等. 三维适形放疗联合TACE治疗肝癌并发门静脉癌栓疗效的Meta分析.实用肝脏病杂志, 2015, 18:254-257.
|
[3] |
Choi JW, Kim HC, Lee JH, et al.Transarterial chemoembolization of hepatocellular carcinoma with segmental portal vein tumour thrombus.Eur Radiol, 2016, 27:1-11.
|
[4] |
中国抗癌协会肝癌专业委员会.原发性肝癌规范化病理诊断指南(2015年版). 中华肝胆外科杂志, 2015, 21:865-872.
|
[5] |
Wu CY, Chen DY, Shen JL, et al.Erratum to: the risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study. Arthritis Res Therapy, 2016, 18:110-117.
|
[6] |
程树群, 杨甲梅, 沈锋,等. 肝细胞癌合并门静脉癌栓多学科诊治——东方肝胆外科医院专家共识. 中华肝胆外科杂志, 2015, 21:582-590.
|
[7] |
Chan A W H, Chong C C N, Mo F K F, et al. Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma: albumin-bilirubin-based Italian staging. J Gastroenterol Hepatol, 2016, 32:221-228.
|
[8] |
Pokhrel D, Sood S, Badkul R, et al.SU-F-T-606: Monte Carlo evaluation of tissue inhomogeneity corrections in the treatment of liver cancer patients using stereotactic body radiotherapy. Med Phys, 2016, 43:3603-3603.
|
[9] |
郭晓笛,孙莎莎,李文东,等.140例BCLC分期C期原发性肝癌患者的临床特征及预后影响因素分析.临床肝胆病杂志,2018,34:1456-1461.
|
[10] |
张长坤, 张龙辉, 王东,等. 术前肝功能Child-Pugh评分与白蛋白-胆红素评分对肝癌患者肝切除术后肝衰竭和预后的预测价值. 中华消化外科杂志, 2018, 17:474-482.
|
[11] |
Oladapo HO, Tarpley M, Sauer SJ, et al.Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells. Cancer Lett, 2017,12:136-149.
|